|
|
Home >
Health Conditions > Glaucoma.
Glaucoma
Related Topics:
Popular Supplements:
Alternative News:
-
Combined use of coenzyme Q10 and citicoline: A new possibility for patients with
glaucoma - Front Med (Lausanne) 2022 Dec 15 -
"Glaucoma is the leading cause of irreversible blindness worldwide. Several risk
factors have been involved in the pathogenesis of the disease. By now, the main
treatable risk factor is elevated intraocular pressure. Nevertheless, some
patients, whose intraocular pressure is considered in the target level, still
experience a progression of the disease. Glaucoma is a form of multifactorial
ocular neurodegeneration with complex etiology, pathogenesis, and pathology. New
evidence strongly suggests brain involvement in all aspects of this disease.
This hypothesis and the need to prevent glaucomatous progression led to a
growing interest in the pharmacological research of new neuroprotective,
non-IOP-lowering, agents. The aim of this paper is to report evidence of the
usefulness of Coenzyme Q10 and Citicoline, eventually combined, in the
prevention of glaucomatous neurodegeneration ... Overall, these data suggest the
possible usefulness of the combined use of citicoline and CoQ10 both in terms of
a putative synergistic effect and in terms of combined action on the different
pathogenetic targets causing the onset and progression of glaucoma. Using
combined treatment may downregulate more pro-apoptotic pathways as well as it
may boost the effect on one or more pathways on which the different molecules
act. In addition, it may increase patients’ compliance reducing the burden of
administering several medications, simplifying treatment" - See
ubiquinol products at Amazon.com and
citicholine at Amazon.com.
-
Natural Products: Evidence
for Neuroprotection to Be Exploited in Glaucoma - Nutrients 2020 Oct 16 -
"Vitamins ... Vitamin A ... Vitamin B Complex ...
Vitamin C ... Vitamin D ... PUFAs ... Palmitoylethanolamide ... Melatonin ...
Citicoline ... Coenzyme Q10 ... Taurine ... Resveratrol ... Forskolin ...
Curcumin ... Lycium barbarum ... Saffron ... Erigeron breviscapus"
-
Improvement
in inner retinal function in glaucoma with nicotinamide (vitamin B3 )
supplementation: A crossover randomized clinical trial - Clin Exp Ophthalmol
2020 Jul 28 - "Participants received oral placebo or
nicotinamide and reviewed six-weekly. Participants commenced 6 weeks of 1.5
g/day then 6 weeks of 3.0 g/day followed by crossover without washout ...
photopic negative response (PhNR) parameters: saturated PhNR amplitude (Vmax),
ratio of PhNR/b-wave amplitude (Vmax ratio) ... PhNR Vmax improved beyond 95%
coefficient of repeatability in 23% of participants following nicotinamide vs 9%
on placebo. Overall, Vmax improved by 14.8% [95% CI: 2.8%, 26.9%], (P = .02) on
nicotinamide and 5.2% [-4.2%, 14.6%], (P = .27) on placebo. Vmax ratio improved
by 12.6% [5.0%, 20.2%], (P = .002) following nicotinamide, 3.6% [-3.4%, 10.5%],
(P = .30) on placebo. A trend for improved visual field mean deviation was
observed with 27% improving ≥1 dB on nicotinamide and fewer deteriorating (4%)
compared to placebo" - [Nutra
USA] - See nicotinamide at Amazon.com.
-
Effect of
palmitoylethanolamide on inner retinal function in glaucoma: a randomized,
single blind, crossover, clinical trial by pattern-electroretinogram - Sci
Rep 2020 Jun 26 - "Glaucoma is a neurodegenerative
disease, our study aimed to evaluate the potential effects of
Palmitoylethanolamide (PEA) supplementation on RGCs function by PERG
examination, and to record effects on intraocular pressure, visual field and
quality of life ... At baseline, most patients had an early visual field defect,
the IOP was well controlled. At the end of the PEA 600 mg supplementation, a
significantly higher (mean 0.56 μV, 95% CI 0.30-0.73, p < 0.001) in the P50-wave
amplitude was observed; in the PEA period a significantly lower IOP (- 1.6 mmHg,
95% CI - 2 to 1.2, p < 0.001) and higher quality of life scores (+ 6.7, 95% CI
4-9.9, p < 0.001) were observed. Our study is the first to show promising
effects of PEA on PERG and on quality of life in glaucoma patients"
-
Turmeric-derived eye drops could treat glaucoma: study - Science Daily,
7/24/18 - "The research team found the eye drops can
reduce the loss of retinal cells in rats, which is known to be an early sign of
glaucoma ... Curcumin is an exciting compound that has shown promise at
detecting and treating the neurodegeneration implicated in numerous eye and
brain conditions from glaucoma to Alzheimer's disease, so being able to
administer it easily in eye drops may end up helping millions of people ...
After twice-daily use of eye drops in the rats for three weeks, retinal ganglion
cell loss was significantly reduced compared to matched controls, and the
treatment was found to be well-tolerated with no signs of eye irritation or
inflammation"
-
Oral Omega-3
Supplementation Lowers Intraocular Pressure in Normotensive Adults - Transl
Vis Sci Technol. 2018 May 1;7(3):1 - "These findings justify further
investigation into the therapeutic potential of omega-3 supplementation for
reducing IOP, to prevent and/or treat conditions with IOP elevation, including
ocular hypertension and glaucoma" - [Nutra
USA] - See omega-3 supplements at
Amazon.com.
-
Vitamin B3 prevents glaucoma in laboratory mice - Science Daily, 2/16/17
- "In mice genetically predisposed to glaucoma,
vitamin B3 added to drinking water is effective at preventing the disease
... The vitamin administration was surprisingly effective, eliminating the
vast majority of age-related molecular changes and providing a remarkably
robust protection against glaucoma. It offers promise for developing
inexpensive and safe treatments for glaucoma patients" - See
vitamin B3 at Amazon.com.
-
Use of Topical
Cannabinomimetic Palmitoylethanolamide in Ocular Surface Disease Associated
with Antiglaucoma Medications - J Ocul Pharmacol Ther 2017 Nov -
"Chronic use of topical hypotensive therapies in
glaucoma patients leads to chronic inflammation of the ocular surface, which
decreases the success rate of long-term glaucoma management. The aim of this
study is to evaluate the effect of topical palmitoylethanolamide (PEA) (Defluxa©),
a well-known anti-inflammatory and analgesic agent, in suppressing the
ocular surface inflammation associated with the use of hypotensive eye drops
... Compared to control, by day 15, the conjunctival hyperemia score was
significantly decreased in the PEA (Defluxa) group (P < 0.01), while the
T-BUT and the Schirmer Test achieved a significant improvement by day 30"
-
Metformin use associated with reduced risk of developing open-angle glaucoma
- Science Daily, 5/28/15 - "patients prescribed the
highest amount of metformin (greater than 1,110 grams in two years) had a 25
percent reduced risk of OAG risk compared with those who took no metformin.
Every one-gram increase in metformin was associated with a 0.16 percent
reduction in OAG risk, which means that taking a standard dose of 2 grams of
metformin per day for two years would result in a 20.8 percent reduction in
risk of OAG ... this study points out the importance of understanding the
potential impact of CR (caloric restriction) mimetic drugs on the risk of
developing other medical conditions that affect older persons"
-
Effect of
palmitoylethanolamide on visual field damage progression in normal tension
glaucoma patients: results of an open-label six-month follow-up - J Med
Food 2014 Sep;17 - "The purpose of this study is to
assess the effect of palmitoylethanolamide (PEA) oral administration on
intraocular pressure (IOP) and visual field damage progression in
normal-tension glaucoma (NTG) patients ... Visual field parameters
significantly diminished in patients receiving PEA compared to baseline
values (-7.65±6.55 dB vs. -4.55±5.31 dB, p<0.001; 5.21±4.08 dB vs. 3.81±3.02
dB ... systemic administration of PEA reduces IOP and improves visual field
indices in individuals affected by NTG"
-
Metformin Linked to
Reduced Risk for Glaucoma - Medscape, 5/13/14 -
"The risk for open-angle glaucoma was 25% lower in patients with documented
cumulative metformin use of more than 1110 g over 2 years (average dose, 2
g/day) than in those with no metformin use ... The association was
dose-dependent, with a 0.01% reduced hazard for open-angle glaucoma with
every 1 g increase in metformin ... The greatest risk reduction was
associated with the highest baseline risk and the highest glycated
hemoglobin (HbA1c) levels ... The findings support the concept that
metformin and some other drugs are geroprotective because they produce
effects that mimic caloric restriction"
-
Omega
3:6 ratio intake and incidence of glaucoma: The SUN cohort - Clin Nutr.
2013 Nov 12 - "followed-up 17,128 participants
initially free of glaucoma for a median time of 8.2 years. Validated data of
diet were collected at baseline with a 136-item semi-quantitative
food-frequency questionnaire and information of new diagnosis of glaucoma in
biennial follow-up questionnaires ... median follow-up time of 8.2 years ...
Participants in the highest quintile of omega 3:6 ratio intake had a
significantly higher risk of glaucoma than participants in the lowest
quintile (hazard ratio (HR): 1.91 [95%CI: 1.05-3.46], p for trend 0.03). The
association became stronger (HR for the comparison of the 5th versus the 1st
quintile: 2.43 [95%CI: 1.17-5.03], p for trend 0.02) when we considered only
those participants who were ≥40 years old" -
See
Mega Twin EPA at Amazon.com
and
Jarrow Max DHA at Amazon.com.
-
Nutrients Promote Eye
Health in Aging, Says Panel - Medscape, 4/17/12 -
"They pointed out that many multivitamin supplements
do not contain nutrients important for eye health, including lutein,
zeaxanthin, and long-chain omega-3 fatty acids. "Taking a supplement
specifically designed for eye health that contains these key nutrients, in
addition to a general nutritional supplement, may therefore be a better
approach to filling dietary shortfalls,""
-
Physical fitness could have a positive effect on eye health - Science
Daily, 10/24/11 - "low ocular perfusion pressure
(OPP), an important risk factor for glaucoma ... From 2006 to 2010, study
participants were examined for eye pressure -- medically termed intraocular
pressure (IOP ) -- and systolic and diastolic blood pressure measurements.
The results showed that moderate physical exercise performed approximately
15 years previously is associated with a 25% reduced risk of low OPP"
-
Ocular hypotensive
effect of oral palmitoyl-ethanolamide: a clinical trial - Invest
Ophthalmol Vis Sci 2011 Aug 3 - "intraocular
pressure (IOP) in primary open angle glaucoma (POAG) and ocular hypertension
(OH) ... 42 patients with POAG or OH who were treated with timolol 0.5% and
whose IOP was between 19 and 24 mm Hg received oral PEA (300-mg tablets
twice a day) or placebo (PEA vehicle tablets twice a day) for 2 months
(period 1), and, after a 2-month washout, received the other treatment for 1
month (period 2) ... After PEA treatment (mean baseline IOP, 21.6 ± 1.7 mm
Hg), IOP was reduced by 3.2 ± 1.3 mm Hg at 1 month and by 3.5 ± 1.2 mm Hg
(15.9% ± 5.1%) at 2 months (ANOVA, P < 0.001; both Tukey-Kramer, P < 0.01
vs. baseline); after placebo (mean baseline IOP, 21.5 ± 1.5 mm Hg), IOP was
reduced by 0.4 ± 1.2 mm Hg at 1 month and by 0.3 ± 1.3 mm Hg at 2 months
(t-test at both time points, P < 0.001 vs. PEA). No statistically
significant vital signs, visual field, visual acuity changes, or adverse
events were detected in either group"
-
Scientists discover new role for vitamin C in the eye and the brain -
Science Daily, 7/15/11 - "cells in the retina need
to be 'bathed' in relatively high doses of vitamin C, inside and out, to
function properly ... Because the retina is part of the central nervous
system, this suggests there's likely an important role for vitamin C
throughout our brains, to a degree we had not realized before ... The
findings could have implications for other diseases, like glaucoma and
epilepsy. Both conditions are caused by the dysfunction of nerve cells in
the retina and brain that become over excited in part because GABA receptors
may not be functioning properly" - See
vitamin C products at Amazon.com.
-
Bilberry-pine bark mix shows eye health benefits - Nutra USA, 5/24/10 -
"One group received daily Mirtogenol supplements (40 mg
Pycnogenol, 80 mg Mirtoselect), one group received Latanoprost eye drops,
and the third group received a combination of both ... After 24 weeks of
intervention, the researchers noted a reduction of blood pressure in the eye
from an average of 38.1 to 29.0 mmHg in the Mirtogenol group, from 37.7 to
27.2 mmHg in the Latanoprost group, and from 38.0 to 23.0 mmHg in the
combined group. Normal eye pressure is reported to range from 10 to 21 mmHg"
-
Green Tea Good for the Eyes? - WebMD, 2/18/10 -
"the compounds responsible for many of the health benefits of green tea are
capable of penetrating the tissues of the eyes and have antioxidant activity
there ... catechins are among a number of antioxidants, including vitamin C,
vitamin E, lutein, and zeaxanthin, thought to help protect the delicate
tissues of the eye from glaucoma and other eye diseases. But until now it
wasn't known if the catechins in green tea were capable of being absorbed
into the tissues of the eye ... The results showed that different parts of
the eye absorbed varying amounts of catechins. The area with the highest
concentration of catechins was the retina, which is the light-sensing tissue
that lines the back of the eye" - [Science
Daily] - See
green tea extract at Amazon.com.
-
Nutritional Strategies for Preventing Age-Related Vision Loss
- Life Extension Magazine, 5/06
-
Bilberry and pine bark combo wards off glaucoma: study - Nutra USA,
7/24/08 - "intra-ocular hypertension (IOP) ... The
bilberry and pine bark product was Mirtogenol, a combination of Indena's
Mirtoselect standardised bilberry extract and Horphag's Pycnogenol pine bark
extract ... IOP was also seen to be lowered in 19 of the 20 intervention
patients, from an average of 25.2mmHg to 22.0mmHG. Only one of the control
patients saw a drop in IOP" - [Abstract]
- See
bilberry at Amazon.com
and
Pycnogenol at Amazon.com.
-
Effects of Mirtogenol
on ocular blood flow and intraocular hypertension in asymptomatic subjects
- Mol Vis. 2008 Jul 10;14:1288-92 - "intraocular
pressure (IOP) ... After two months of supplementation with Mirtogenol, the
mean IOP decreased from a baseline of 25.2 mmHg to 22.2 mmHg. After three
months of treatment with Mirtogenol, the IOP was significantly lowered
compared to that of untreated controls (p<0.05) to 22.0 mmHg" - [Nutra
USA] - See
bilberry at Amazon.com
and
Pycnogenol at Amazon.com.
- Tight Necktie
May Boost Glaucoma Risk - WebMD, 7/28/03 -
"a too-tight necktie may increase the risk of
glaucoma by boosting blood pressure inside the eyes to dangerous levels"
- Ginkgo Improves Some
Glaucoma - New Hope Natural Media, 5/16/03 -
"27 people with normal tension glaucoma and visual
field losses were randomly assigned to one of two groups. One group received
40 mg of Ginkgo biloba extract three times per
day for four weeks, followed by eight weeks with no treatment and finally
four weeks of placebo. The other group received placebo for four weeks,
followed by the same eight weeks with no treatment and ending with four
weeks of Ginkgo biloba. Both groups experienced significant improvement
(approximately 24%) in indices used to evaluate visual fields after
treatment with Ginkgo biloba. There were no improvements for either group
during placebo phases ... Ginkgo biloba extract has several properties that
might have contributed to the beneficial effects observed in this trial. Its
antioxidant activity might have protected the optic nerve from oxidative
damage, and its ability to increase blood flow and oxygen utilization might
have protected the optic nerve from damage due to lack of oxygen" -
See
ginkgo biloba at Amazon.com.
Other News:
-
Long-term statin use associated with lower glaucoma risk - Science Daily,
6/26/19 - "While previous observational studies have
been inconsistent about the association of primary open-angle glaucoma risk with
long-term cholesterol and statin use, the results showed that use of statins for
five years or longer, versus never using statins, is associated with a 21
percent lower chance of primary open-angle glaucoma. In addition, every 20 mg/dL
increase in total serum cholesterol level is associated with a 7 percent
increase in risk of primary open-angle glaucoma. These results suggest that
elevated cholesterol levels may heighten glaucoma risk"
-
CBD in
marijuana may worsen glaucoma, raise eye pressure - Science Daily, 12/17/18
- "One of the most commonly proposed uses of medical
marijuana is to treat glaucoma ... But a study from researchers at Indiana
University has found that a major chemical component in the substance appears to
worsen the primary underpinning of the disease: a rise in pressure inside the
eye"
-
Three Eye Conditions
Linked to Higher Alzheimer's Risk - Medscape, 8/14/18 -
"Participants recently diagnosed with glaucoma had a 46%
increased likelihood of developing AD. Similarly, the risk among those recently
diagnosed with AMD or diabetic retinopathy had a 50% increased AD risk compared
with their counterparts without these conditions"
- Gum Disease Connected
to Open-Angle Glaucoma - Medsacpe, 3/14/16 -
"The hypothesis for this link is that local infection and inflammation at
the base of the tooth could release factors that travel to the eye and
trigger an inflammatory response that could lead to the development of
glaucoma ... The risk for primary open-angle glaucoma was 43% higher in men
who reported the loss of one or more teeth at the most recent update than in
men who reported no lost teeth ... And the risk for primary open-angle
glaucoma was an 86% higher in men who reported any tooth loss with
periodontal disease"
-
Long-term oral contraceptive users twice as likely to have serious eye
disease - Science Daily, 11/18/13 - "females who
had used oral contraceptives, no matter which kind, for longer than three
years are 2.05 times more likely to also report that they have the diagnosis
of glaucoma"
- Do Statins Protect
Against Glaucoma? - Medscape, 5/13/13 -
"open-angle glaucoma (OAG) ... used a nationwide healthcare claims database
containing detailed medical records for more than 500,000 patients with
hyperlipidemia to determine whether an association exists between statin use
and the development of OAG ... the risk for OAG decreased 0.3% (adjusted
hazard ratio [HR], 0.997; 95% confidence interval [CI], 0.994-0.999) for
every additional month of statin use. Individuals with hyperlipidemia who
took statins continuously for 2 years had an 8% (adjusted HR, 0.922; 95% CI,
0.870-0.976) lower OAG risk compared with those who received no statin
therapy"
- Do Glaucoma,
Erectile Dysfunction Have a Common Cause? - Medscape, 2/7/12 -
"Men with erectile dysfunction (ED) have a nearly
3-fold greater risk for also having open-angle glaucoma (OAG) than men with
normal erectile function ... The study suggests that OAG and ED appear to
have a common mechanism of endothelial dysfunction related to nitric oxide"
-
New Glaucoma Procedure Aims To Prevent Further Eye Damage - Science
Daily, 6/25/08
- FDA Approves
Allergan Combo Eye Drop for Glaucoma - Medscape, 10/31/07
-
Glaucoma Surgery In The Blink Of An Eye - Science Daily, 9/11/07
-
Alzheimer's Disease Linked To Glaucoma - Science Daily, 8/6/07
- Advances in
Glaucoma: Progression, Compliance, and Quality of Life - Medscape,
6/19/07
-
Type 2 Diabetes Increases The Risk Of Glaucoma In Women - Science Daily,
7/12/06
-
Study Demonstrates Benefits of Combination Treatment for Glaucoma -
Doctor's Guide, 5/11/06
-
Prostaglandin Analog Improves Results of Selective Laser Trabeculoplasty
- Doctor's Guide, 5/3/06
-
Pegaptanib Sodium Leads to Significant Increase in Intraocular Pressure in
Patients With Pre-Existing Glaucoma - Doctor's Guide, 5/1/06
-
Sub-Tenon Anecortave Acetate Lowers Intraocular Pressure in Patients With
Open Angle Glaucoma - Doctor's Guide, 5/1/06
-
Brinzolamide 1% Found More Effective Than Brimonidine 0.15% When Added to
Travoprost in Glaucoma Patients - Doctor's Guide, 5/1/06
-
Glaucoma Patients Appear to Have Increased Eye Pressure During Sleep -
Doctor's Guide, 2/16/06
-
No difference in Reduction of Intraocular Pressure Between Bimatoprost and
Travoprost in African Americans With Glaucoma - Doctor's Guide, 10/20/05
-
Selective Laser Trabeculoplasty Helps Glaucoma Patients Reduce Reliance on
Ocular Hypotensive Medications: Presented at AAO - Doctor's Guide,
10/18/05
-
New Formulation of Allergan's Alphagan P Receives U.S. FDA Approval -
Doctor's Guide, 8/19/05
-
Glaucoma Patients Playing Dangerous Game to Make Their Drops Last Longer
- Doctor's Guide, 5/9/05
-
Two Prostaglandins Largely Similar in Intraocular Pressure Reduction for
Glaucoma Patients - Doctor's Guide, 5/9/05
-
Fixed-Dose Xalacom (latanoprost/timolol) Effective in Treating Glaucoma, and
Patients Express Strong Preference for Single-Drop Regimen - Doctor's
Guide, 5/9/05
-
Timolol-Dorzolamide Lowers Intraocular Pressure in Glaucoma Patients the
Same as Timolol-Latanoprost - Doctor's Guide, 5/6/05
-
Response to Glaucoma Drugs Different in Opposite Eyes - Doctor's Guide,
5/5/05
-
Heavy Computer Use Linked to Glaucoma - WebMD, 11/15/04
-
Columbia Research Shows Central Corneal Thickness Significantly Impacts
Glaucoma Treatment - Science Daily, 9/28/04
-
Corneal Thickness May Influence Decision Regarding Treatment Options for
Patients with Glaucoma - Doctor's Guide, 9/13/04
-
New Approach to Assessing Glaucoma Risk May Help Treatment Decisions -
Doctor's Guide, 9/13/04
-
Latanoprost Safe, Well Tolerated For Glaucoma Treatment - Doctor's
Guide, 7/13/04
-
Long-Term Use of Statins May Protect Against Glaucoma - Doctor's Guide,
6/22/04
-
Daily Eye Drops Hold Key To Glaucoma Prevention - Science Daily, 6/17/04
- Cholesterol
Drugs May Fight Glaucoma - WebMD, 6/14/04 -
"men who had used statins for two or more years were
40% less likely to develop glaucoma than the others ... Use of other,
non-statin cholesterol-lowering drugs was also associated with a 41% lower
incidence of glaucoma ... use of statins can also lower the risk of
developing age-related macular degeneration, the most common cause of
blindness among people over 65"
-
FDA Approves Istalol (Timolol) for Treatment of Glaucoma - Doctor's
Guide, 6/7/04
-
Latest Progress in Neuroprotective Therapies - Doctor's Guide, 5/3/04
- Latanoprost More
Effective Than Timolol at Lowering Intraocular Pressure - Medscape,
2/11/04
-
Ex-PRESS Implant Reduces Intraocular Pressure in Patients With Open-Angle
Glaucoma - Doctor's Guide, 11/20/03
-
Benefits and Shortcomings of Anti-Tumour Necrosis Factor Drugs in
Spondyloarthritis - Doctor's Guide, 7/28/03
-
FDA Issues Approvable Letter For Istalol (Timolol), Treatment For Glaucoma
- Doctor's Guide, 7/28/03
- Selective Laser
Trabeculoplasty Safe, Effective for Open-Angle Glaucoma - Medscape,
7/21/03
-
Elevated Homocysteine Linked to Exfoliative Syndrome and Exfoliative
Glaucoma - Doctor's Guide, 6/11/03
-
Patients with Stable Glaucoma More Likely to be Depressed than Those with
Progressive Disease - Doctor's Guide, 5/8/03
-
Glaucoma Response Seen with Bimatoprost in Latanoprost Non-Responders -
Doctor's Guide, 3/28/03
-
Argon Laser Trabeculoplasty Plus Topical Betaxolol Halves Progression Risk
Of Open-Angle Glaucoma - Doctor's Guide, 3/3/03
-
Xalatan for Elevated Eye Pressure - Physician's Weekly, 2/24/03
-
Eye Pressure Appears To Be Lowered More Significantly With Lumigan
(Bimatoprost) Than Xalatan (Latanoprost) - Doctor's Guide, 1/28/03
- Early Glaucoma
Treatment Saves Sight - WebMD, 1/24/03
- Reducing IOP Lowers
Risk of Progression in Early Open-Angle Glaucoma - Medscape, 1/21/03
-
Ibopamine More Potent Mydriatic Than Phenylephrine Or Tropicamide -
Doctor's Guide, 1/13/03
- Latanoprost Approved
for First-Line Treatment of Elevated IOP - Medscape, 1/2/03
-
FDA Grants Marketing Approval To Xalatan (Latanoprost) For Initial Treatment
Of Elevated Eye Pressure - Doctor's Guide, 12/23/02
-
Elderly Risk Airways Obstruction From Beta Blockers For Glaucoma -
Doctor's Guide, 12/13/02
-
Clinical Evaluation of Uveitis-Associated Secondary Glaucoma - Doctor's
Guide, 12/11/02
-
Epithelial Barrier Function Remains Intact Following Topical Latanoprost for
Glaucoma - Doctor's Guide, 11/18/02
-
Glaucoma Is "Devastating" Complication Of Repeated Corneal Transplantation
- Doctor's Guide, 11/11/02
-
Bimatoprost, Timolol Compared For Glaucoma And Ocular Hypertension -
Doctor's Guide, 10/28/02
-
Leaking Conjunctival Blebs Treated with Autologous Serum and Oxifloxacin
- Doctor's Guide, 10/25/02
-
Scleral Expansion Bands Show Promise in Patients with Open Angle Glaucoma
- Doctor's Guide, 10/25/02
-
Little Long Term Difference Between Surgical and Medical Management of Newly
Diagnosed Glaucoma - Doctor's Guide, 10/23/02
-
Normal Tension Glaucoma and Optic Neurolopathy Different from Other
Glaucomas - Doctor's Guide, 10/22/02
-
Elevated Homocysteine May Be Linked to Glaucoma - Doctor's Guide,
10/22/02 - "Hyperhomocysteinemia
could be a significant risk factor for a particular type of glaucoma"
-
LASIK "Probably" Safe for Patients with Glaucoma - Doctor's Guide,
10/21/02
-
Immediate Treatment Helps Delay Progression Of Glaucoma - Doctor's
Guide, 10/14/02
- Glaucoma
Screening Saves Sight - WebMD, 10/14/02
-
Trabeculectomy, Drug Monotherapy Compared - Doctor's Guide, 10/7/02
- Caffeine May Worsen
Glaucoma - Nutrition Science News, 6/27/02 -
"Compared with decaffeinated
coffee, regular coffee produced a statistically significant increase in
IOP at both 60 and 90 minutes. The magnitude of the increase was
approximately 2 to 3 mm Hg, an amount that, if sustained over the long term,
could have an adverse effect on visual function"
-
Changes in Optic Nerve Head Blood Flow Affect Finger Flood Flow in Patients
with Open-Angle Glaucoma - Doctor's Guide, 6/17/02
-
Eye Drops Delay Onset Of Glaucoma In People At Higher Risk - Doctor's
Guide, 6/14/02
-
Xalacom (latanoprost/timolol) More Effective than Cosopt
(dorzolamide/timolol) for IOP Reduction in Patients with Glaucoma or Ocular
Hypertension in New Study - Doctor's Guide, 5/8/02
-
New Study Finds Patients' Intraocular Pressure Improved When Switched to
Xalatan® from Other Monotherapy - Doctor's Guide, 5/8/02
-
Brimonidine-Purite Comparable to Brimonidine Alone in Lowering Intraocular
Pressure - Doctor's Guide, 4/26/02
-
Latanoprost, Brimonidine Reduce Intraocular Pressure in Glaucoma -
Doctor's Guide, 4/11/02
-
Glaucoma Leading Cause of Blindness in U.S. Hispanics - Doctor's Guide,
4/5/02
- Travatan (Travoprost)
Shows Efficacy for Glaucoma, Especially in African Americans - Doctor's
Guide, 2/4/02
-
Glaucoma: Trabeculectomy Increases Cataract Risk - Doctor's Guide,
12/28/01
- New Procedure for Glaucoma
Proves as Effective as Medication - Doctor's Guide, 11/16/01
- Combination Of Latanoprost
And Timolol Superior To Each Drug Individually - Doctor's Guide,
11/16/01
- Largest Head-To-Head Trial
To Date Favors Bimatoprost Over Latanoprost For Glaucoma Treatment -
Doctor's Guide, 11/15/01
- Travatan (Travaprost)
Superior to Timoptic (Timolol) in Patients with Moderate and Severely
Elevated Intra-Ocular Pressure - Doctor's Guide, 11/13/01
- Brimonidine/Latanoprost
Combination Lowers Intra-Ocular Pressure More Than Latanoprost/Timolol -
Doctor's Guide, 11/14/01
- Intra-Ocular Pressure
Lowering Drugs, Cosopt (Timolol Maleate), Alphagan (brimondine)/Timolol
Combination Equally Effective - Doctor's Guide, 11/12/01
- Genetic Test, OcuGene, for
the Management, Detection of Glaucoma Launched in US - Doctor's Guide,
10/10/01
- FDA Approves Alphagan P to
Treat Intraocular Pressure - Doctor's Guide, 3/16/01
-
FDA Approves Travatan (Travoprost) 0.004% Solution For Reducing Elevated
Intraocular Pressure - Doctor's Guide, 5/18/01
-
FDA Clears Two Glaucoma Drugs - Intelihealth, 3/17/01 -
"Both Travatan and Lumigan work by draining fluid
buildup that is the hallmark of glaucoma"
-
New Device Helps To Diagnose Glaucoma More Reliably - Intelihealth,
3/14/01
- Betimol (Timolol
Ophthalmic Solution), For Open-Angle Glaucoma, Now Available In US -
Doctor's Guide, 1/11/01
-
Side-effects Of Brimonidine May Be Greater Than Previously Reported -
Doctor's Guide, 11/10/00
- Brimonidine Offers Same
Efficacy, Quality Of Life As Betaxalol - Doctor's Guide, 10/26/00
- Xalatan (Latanoprost)
Reduces Intraocular Eye Pressure Better Than Trusopt (Dorzolamide) -
Doctor's Guide, 10/17/00
- Keep a Watchful
Eye on the Silent Thief of Sight - WebMD, 7/7/00
- Xalatan Effective For
Open-Angle Glaucoma - Doctor's Guide, 12/16/99
-
Study Suggests New Way To Block Blindness From Glaucoma - Intelihealth,
8/17/99
- Glaucoma Blindness Risk In
Caucasians Higher Than Previously Thought - Doctor's Guide, 12/1/98
- Xalatan Monotherapy
Equivalent To Timolol/Dorzolamide Combination For IOP - Doctor's Guide,
11/11/98
- FDA Approves Cosopt
Combination Eye Drops - Doctor's Guide, 4/8/98
- Xalatan Solution Now
Available for Glaucoma Treatment - Doctor's Guide, 9/17/96
- Xalatan Ophthalmic Solution
Cleared by FDA for Open-Angle Glaucoma - Doctor's Guide, 6/6/96
|
|